Navigation Links
Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Date:4/10/2008

activity of a new PI3K inhibitor PX-866 for

treatment of human glioblastoma

Abstract # 3731, Session: Imaging in Preclinical and Clinical

Therapeutics

Poster Session: Tuesday, April 15, 2008, 8:00 a.m. to

12:00 p.m. PT

- Identification of novel synergistic targets RACK-1 and galectin-1 for

rational drug combinations with PI3 Kinase inhibitors using siRNA

synthetic lethality screening

Abstract # 2761, Session: Signal Transduction and Therapeutics

Poster Session: Monday, April 14, 2008, 1:00 p.m. to

5:00 p.m. P.T.

- Phosphatidylinositol 3-kinase stimulates the proliferation of

bronchioalveolar stem cells in mouse models of oncogenic K-ras-

induced lung cancer

Abstract # 5408, Session: Stem Cells

Poster Session: Wednesday, April 16, 2008, 8:00 a.m. to

12:00 p.m. P.T.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.

Forward Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements related to future clinical development plans for PX-12 and PX-866. These forward-looking statements represent Oncothyreon's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events an
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncothyreon announces effectiveness of shelf registration statement
2. Oncothyreon announces issuance of patent for PX-867
3. Oncothyreon to present at upcoming investment conferences
4. Oncothyreon reports full year and fourth quarter 2007 financial results
5. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
6. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
7. Oncothyreon launches new corporate website
8. Oncothyreon to present at BIO CEO & Investor Conference
9. Oncothyreon highlights corporate and clinical objectives for 2008
10. Biomira announces plan to change name to Oncothyreon
11. Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, yet ... body part. Similar to the liver, or heart, the skin ... and grow. Recent reports from the mankatofreepress.com explained how caring ... important as other life supporting organs. The article suggests several ... reproduction, increase the appearance of skin, and fight off acne ...
(Date:6/18/2013)... , June 18, 2013 ... the release of the HELM biomolecular representation standard ... source MIT licence. HELM (Hierarchical Editing ... wide range of biomolecules (e.g. proteins, nucleotides, antibody ... small-molecule and sequence-based informatics methodologies impractical or unusable. ...
(Date:6/18/2013)... 2013 The "Bioinformatics Market By Sector (Molecular ... Tools & Data Analysis Services) & Application (Genomics, Proteomics & ... Market Drivers, Restraints, and Opportunities in North America ... and Rest of World. Browse ... 22 Figures 364 Pages and ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... (bortezomib) for Injection sales grew 20% to $265 million in ... ... myeloma -,- MLN0002 core bridging studies fully enrolled, showing favorable results - ... - On track to exceed 2007 net income financial guidance ...
... development programs, including review of positive results from the Phase ... ... Jan. 4 QuatRx Pharmaceuticals Company,today announced that the company chief ... 26th Annual JP Morgan Healthcare,Conference on Tuesday, January 8th, 2008, at ...
... AutoGenomics announced today,that the Company has been invited ... which is being held January 7-10, 2008 at,the Westin ... conference,Fareed Kureshy President and Chief Executive Officer will provide ... January 8, 2008., About JPMorgan 26th Annual Healthcare ...
Cached Biology Technology:Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 2Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 3Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 4Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 5Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 6Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 7Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 8Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 9QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 2
(Date:6/17/2013)... Employment and Entrepreneurship will be the topics under ... 26th June. For the third consecutive year, this ... and sharing of experiences among members of Academy, ... PhD students. Confirmed speakers: Elisa Martn Garijo (IBM ... (Branching Tree) and Mary O,Donovan (Hovione), among others. ...
(Date:6/16/2013)... sex workers in India reduce rates of syphilis, HIV ... Toronto study has found. , About two ... southern states of Andhra Pradesh, Karnataka, Maharashtra and Tamil ... U of T,s Dalla Lana School of Public Health ... (CGHR), examined the impact of prevention among female sex ...
(Date:6/15/2013)... A drug approved in Europe to treat osteoporosis has ... cancer cells, even in cancers that have become resistant ... Institute study. , The findings, presented June 15, 2013, ... indicate that the drug bazedoxifene packs a powerful one-two ... cancer cell growth, but also flags the estrogen receptor ...
Breaking Biology News(10 mins):'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2HIV prevention among female sex workers in India reduces HIV and syphilis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... selected for BOSS-U $497 million awardRESTON, Va., Jan. ... Force has selected Raytheon Company (NYSE: ... to enhance the ability of the Department of ... capabilities. The Biometrics Operations and Support Services - ...
... (January 27, 2009) -- The Wildlife Conservation Society (WCS) ... jaguars in the Amazon region of Ecuadorone of the ... The ongoing census, which began in 2007, is working ... subsequent development puts growing pressure on wildlife in Ecuador,s ...
... the question at some stage in their professional career: ... reviewed disappeared into the ether? Scientists, like ... peer review, researchers want to learn whether their paper ... Unfortunately, the review process rarely seems to work in ...
Cached Biology News:Raytheon Chosen to Help Provide Department of Defense Biometrics Operations and Support Services 2Big cats, wild pigs and short-eared dogs -- oh, my! 2A re-review of peer review: Leading journal looks to end the 'review nightmare' 2
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
Goat polyclonal to HA1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: TLGSCRERQPEFV from the C terminus of human HA1. Entrez GeneID: 23526 Swiss Protein ID: O78181...
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
Rabbit polyclonal to TAB1 ( Abpromise for all tested applications). entrezGeneID: 10454 SwissProtID: Q15750...
Biology Products: